Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · USD
$13.7
-1.32 (-8.8%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first SMMT analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 10.9B | |
|---|---|---|
| Net income (ttm) | -856.1M | |
| EPS (ttm) | -$1.12 | |
| Shares out | 797.7M | |
| Volume | 8,153,726 | |
| Beta | -1.26 | |
| Price target | $28.1 | +105.5% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -856.1M
- EPS (ttm)
- -$1.12
- Market cap
- 10.9B
Fair-value bridge
- Current price
- $13.7
Analyst consensus
Recommendation
Buy
Price target
$28.1
+105.5%
In the news
Latest news · SMMT
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 10.9B
- P/B
- 17.2x
- EV / EBITDA
- 11.7x
Profitability
- ROE
- -192.5%
- ROA
- -101.6%
- ROIC
- -119.5%
Balance sheet
- Debt / equity
- 0.03
- Current ratio
- 6.96
- Quick ratio
- 6.67
Trading
- Beta
- -1.26
- Volume
- 8,153,726
- Dividend yield
- 0.0%